The negative outlook reflects that we may lower the rating in the next 12 months. This could stem from adverse market conditions, notably linked to the pandemic, the deterioration in auto markets, and the weakening of upstream chemicals margins. Notably, adjusted FFO to debt of below 25%, which is lower than the weak 2019 level, has significantly weighed on the rating. We could downgrade BASF if it failed to swiftly improve its S&P Global Ratings-adjusted FFO-to-debt ratio to 35% by 2021. This would rely on timely market recovery, disciplined capex, and efficient working capital management. The current rating on BASF also relies on the progress of the IPO of Wintershall Dea, now in our base case. At least neutral discretionary